Glycated Hemoglobin A

"Glycated Hemoglobin A" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Products of non-enzymatic reactions between GLUCOSE and HEMOGLOBIN A, occurring as a minor fraction of the hemoglobin components of human erythrocytes. Hemoglobin A1c is hemoglobin A with glucose covalently bound to the terminal VALINE of the beta chain. Glycated hemoglobin A is used as an index of the average blood sugar level over a lifetime of erythrocytes.

Descriptor ID	D006442
MeSH Number(s)	D09.400.430.937 D12.776.124.400.405.440 D12.776.395.381 D12.776.422.316.762.380.440
Concept/Terms	Glycated Hemoglobin A Glycated Hemoglobin A Hemoglobin A, Glycated Hb A1a+b Hb A1c HbA1 Glycosylated Hemoglobin A Hemoglobin A, Glycosylated Hb A1 Glycohemoglobin A Hemoglobin A(1) Hb A1a-2 Hb A1a-2 Hemoglobin, Glycated A1a-2 A1a-2 Hemoglobin, Glycated Glycated A1a-2 Hemoglobin Hemoglobin, Glycated A1a 2 Hemoglobin, Glycosylated A1a-1 Hemoglobin, Glycosylated A1a-1 A1a-1 Hemoglobin, Glycosylated Glycosylated A1a-1 Hemoglobin Hemoglobin, Glycosylated A1a 1 Hb A1a-1 Hemoglobin, Glycated A1b Hemoglobin, Glycated A1b A1b Hemoglobin, Glycated Glycated A1b Hemoglobin Hb A1b Hemoglobin, Glycosylated A1b A1b Hemoglobin, Glycosylated Glycosylated A1b Hemoglobin Glycated Hemoglobin A1c Glycated Hemoglobin A1c Hemoglobin A1c, Glycated Glycosylated Hemoglobin A1c Hemoglobin A1c, Glycosylated Glycated Hemoglobins Glycated Hemoglobins Hemoglobins, Glycated Hemoglobin, Glycosylated Glycosylated Hemoglobin

Below are MeSH descriptors whose meaning is more general than "Glycated Hemoglobin A".

Chemicals and Drugs [D]
Carbohydrates [D09]
Glycoconjugates [D09.400]
Glycoproteins [D09.400.430]
Glycated Hemoglobin A [D09.400.430.937]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Blood Proteins [D12.776.124]
Hemoglobins [D12.776.124.400]
Hemoglobin A [D12.776.124.400.405]
Glycated Hemoglobin A [D12.776.124.400.405.440]
Glycoproteins [D12.776.395]
Glycated Hemoglobin A [D12.776.395.381]
Hemeproteins [D12.776.422]
Globins [D12.776.422.316]
Hemoglobins [D12.776.422.316.762]
Hemoglobin A [D12.776.422.316.762.380]
Glycated Hemoglobin A [D12.776.422.316.762.380.440]

Below are MeSH descriptors whose meaning is more specific than "Glycated Hemoglobin A".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Glycated Hemoglobin A" by people in this website by year, and whether "Glycated Hemoglobin A" was a major or minor topic of these publications.

Bar chart showing 10 publications over 5 distinct years, with a maximum of 4 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2016	1	0	1
2017	0	4	4
2018	0	2	2
2021	0	2	2
2022	0	1	1

Below are the most recent publications written about "Glycated Hemoglobin A" by people in Profiles.

Malik FS, Sauder KA, Isom S, Reboussin BA, Dabelea D, Lawrence JM, Roberts A, Mayer-Davis EJ, Marcovina S, Dolan L, Igudesman D, Pihoker C, Lawrence JM, Hung P, Koebnick C, Li X, Lustigova E, Reynolds K, Pettitt DJ, Mayer-Davis EJ, Mottl A, Thomas J, Jackson M, Knight L, Liese AD, Turley C, Bowlby D, Amrhein J, Apperson E, Nelson B, Dabelea D, Bellatorre A, Crume T, Hamman RF, Sauder KA, Shapiro A, Testaverde L, Klingensmith GJ, Maahs D, Rewers MJ, Wadwa P, Daniels S, Kahn MG, Wilkening G, Bloch CA, Powell J, Love-Osborne K, Hu DC, Dolan LM, Shah AS, Standiford DA, Urbina EM, Pihoker C, Hirsch I, Kim G, Malik FA, Merjaneh L, Roberts A, Taplin C, Yi-Frazier J, Beauregard N, Franklin C, Gangan C, Kearns S, Klingsheim M, Loots B, Pascual M, Greenbaum C, Imperatore G, Saydah SH, Linder B, Marcovina SM, Chait A, Clouet-Foraison N, Harting J, Strylewicz G, D'Agostino R, Jensen ET, Wagenknecht LE, Bell RA, Casanova R, Divers J, Goldstein MT, Henkin L, Isom S, Lenoir K, Pierce J, Reboussin B, Rigdon J, South AM, Stafford J, Suerken C, Wells B, Williams C. Trends in Glycemic Control Among Youth and Young Adults With Diabetes: The SEARCH for Diabetes in Youth Study. Diabetes Care. 2022 02 01; 45(2):285-294.

View in: PubMed
Rising KL, Kemp M, Davidson P, Hollander JE, Jabbour S, Jutkowitz E, Leiby BE, Marco C, McElwee I, Mills G, Pizzi L, Powell RE, Chang AM. Assessing the impact of medically tailored meals and medical nutrition therapy on type 2 diabetes: Protocol for Project MiNT. Contemp Clin Trials. 2021 09; 108:106511.

View in: PubMed
Powell RE, Zaccardi F, Beebe C, Chen XM, Crawford A, Cuddeback J, Gabbay RA, Kissela L, Litchman ML, Mehta R, Meneghini L, Pantalone KM, Rajpathak S, Scribner P, Skelley JW, Khunti K. Strategies for overcoming therapeutic inertia in type 2 diabetes: A systematic review and meta-analysis. Diabetes Obes Metab. 2021 09; 23(9):2137-2154.

View in: PubMed
Kansagara D, Qaseem A, Wilt TJ. Guidelines on Glycemic Targets for Persons With Type 2 Diabetes. JAMA. 2018 11 13; 320(18):1937.

View in: PubMed
Mathieu C, Dandona P, Gillard P, Senior P, Hasslacher C, Araki E, Lind M, Bain SC, Jabbour S, Arya N, Hansen L, Thorén F, Langkilde AM. Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial. Diabetes Care. 2018 09; 41(9):1938-1946.

View in: PubMed
Shohat N, Tarabichi M, Tischler EH, Jabbour S, Parvizi J. Serum Fructosamine: A Simple and Inexpensive Test for Assessing Preoperative Glycemic Control. J Bone Joint Surg Am. 2017 Nov 15; 99(22):1900-1907.

View in: PubMed
Asleh R, Briasoulis A, Schettle SD, Tchantchaleishvili V, Pereira NL, Edwards BS, Clavell AL, Maltais S, Joyce DL, Joyce LD, Daly RC, Kushwaha SS, Stulak JM. Impact of Diabetes Mellitus on Outcomes in Patients Supported With Left Ventricular Assist Devices: A Single Institutional 9-Year Experience. Circ Heart Fail. 2017 Nov; 10(11).

View in: PubMed
Dasgupta I, Singh AK. Review: In diabetes, intensive and standard glycemic control do not differ for end-stage kidney disease or death. Ann Intern Med. 2017 10 17; 167(8):JC47.

View in: PubMed
Davies M, Pieber TR, Hartoft-Nielsen ML, Hansen OKH, Jabbour S, Rosenstock J. Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial. JAMA. 2017 10 17; 318(15):1460-1470.

View in: PubMed
Munch L, Arreskov AB, Sperling M, Overgaard D, Knop FK, Vilsbøll T, Røder ME. Risk stratification by endocrinologists of patients with type 2 diabetes in a Danish specialised outpatient clinic: a cross-sectional study. BMC Health Serv Res. 2016 Apr 09; 16:124.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement